









Markets
/
Stocks
/
nasdaq-maze
/

Maze Therapeutics Inc

MAZE

42.100USD

+0.020+0.05%

Close 12/26, 16:00（ET）Quotes delayed by 15 min

2.02BMarket Cap

LossP/E TTM



Maze Therapeutics Inc

42.100

+0.020+0.05%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

You can check out the annual or quarterly balance sheets of Maze Therapeutics Inc here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

Total equity

Cash, cash equivalents and short-term investments

156.63%383.94M

51.11%264.54M

--294.37M

--196.81M

--149.61M

--175.06M

- Cash and cash equivalents

111.74%316.77M

51.11%264.54M

--294.37M

--196.81M

--149.61M

--175.06M

-Short-term investments

--67.16M

----

Prepaid expenses

69.40%7.37M

52.49%6.61M

--5.33M

--4.86M

--4.35M

--4.33M

Other current assets

----

--0.00

----

Total current assets

154.16%391.30M

51.14%271.15M

--299.71M

--201.67M

--153.96M

--179.40M

Non-current assets

Net Fixed Assets

-14.46%26.46M

-13.84%27.71M

--28.80M

--29.92M

--30.93M

--32.16M

Other non-current assets

-43.39%4.30M

10.07%4.66M

--4.34M

--8.95M

--7.59M

--4.23M

Total non-current assets

-20.16%30.76M

-11.06%32.37M

--33.13M

--38.87M

--38.52M

--36.40M

Total assets

119.27%422.06M

40.65%303.52M

--332.84M

--240.54M

--192.48M

--215.79M

Liabilities

Current liabilities

-Other payables

----

--0.00

----

Accrued expenses

23.30%14.43M

8.41%11.52M

--11.54M

--14.10M

--11.70M

--10.62M

Deferred liabilities

----

--2.50M

Other current liabilities

----

-100.00%0.00

--0.00

----

--2.50M

Total current liabilities

25.96%22.11M

-7.89%19.90M

--18.62M

--20.67M

--17.55M

--21.61M

Non-current liabilities

Long-term debt and lease liabilities

-73.95%19.42M

-72.07%20.29M

--21.15M

--22.00M

--74.54M

--72.66M

-Long-term debt

----

--0.00

--51.75M

--49.10M

-Long-term lease liabilities

-14.81%19.42M

-13.88%20.29M

--21.15M

--22.00M

--22.80M

--23.56M

Other non-current liabilities

7.81%1.09M

--1.09M

--1.01M

--969.00K

--1.01M

----

Total non-current liabilities

-72.85%20.51M

-70.57%21.38M

--22.16M

--22.96M

--75.56M

--72.66M

Total liabilities

-54.22%42.62M

-56.21%41.28M

--40.77M

--43.64M

--93.11M

--94.27M

Shareholders' equity

Common equity

2743.33%834.35M

2468.61%687.13M

--683.28M

--47.24M

--29.34M

--26.75M

Retained earnings

-44.96%-454.98M

-46.96%-424.89M

---391.21M

---358.43M

---313.88M

---289.12M

Capital reserves

2743.36%834.30M

2470.66%687.09M

--683.24M

--47.24M

--29.34M

--26.73M

Gains losses not affecting retained earnings

--69.00K

----

Total equity

281.84%379.44M

115.78%262.24M

--292.07M

--196.90M

--99.37M

--121.53M

Currency unit

USD

Audit opinions

FAQs

What is the balance sheet?



It is a financial report that summarises the assets, liabilities, and shareholders’ equity of a company at a specific point in time.

KeyAI

